Preview
Unable to display preview. Download preview PDF.
Références
Parkin DM, Bray F, Ferlay J et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108
Rotkin ID (1973) A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 33: 1353–67
Meisels A, Morin C (1981) Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 12: S111–S123
Zur Hausen H (2002) Papillomavirus and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–50
Orth G (1988) Nouvelles perspectives dans le domaine du dépistage précoce et de la prévention des précurseurs des cancers du col de l’utérus. « Chercher pour Agir, Recherche d’aujourd’hui, Médecine d’aujourd’hui et de demain » 2e Colloque CNAMTS-INSERM 187: 87–94
Schiffman M, Herrero R, DeSalle R et al. (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337: 76–84
Howley PM, Lowy DR (2001) Papillomaviruses and their replication. In: Fields Virology, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds). Vol. 2. p 2197–330 Lippincott William & Wilkins: Philadelphia
Orth G (1999) Papillomaviruses-human (Papovaviridae): General features. 2nd edition. In Encyclopedia of Virology (RG Webster and A Granhoff, eds.), vol 2: 1105–14. Academic Press Ltd., London
Ramoz N, Rueda LA, Bouadjar B et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579–81
Munoz N, Bosch FX, de Sanjosé S et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518–27
Orth G, Croissant O (1997) Papillomavirus humains et carcinogenèse du col utérin: perspectives dans les domaines du dépistage et de la prévention. Bull Acad Natle Méd 181: 1365–94
Alonso L, Fuchs E (2003) Stem cells of the skin epithelium. Proc Natl Acad Sci USA 100: 11830–5
Münger K, Baldwin A, Edwards KM et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451–60
Duensing S, Münger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109: 157–62
Schiffman M, Kjaer SK (2003) Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31: 14–9
Iftner T, Villa LL (2003) Human papillomavirus technologies. J Natl Cancer Inst Monogr 31: 80–8
Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32, Supplement 1: 16–24
Castle PE, Schiffman M, Herrero R et al. (2005) A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste Costa Rica. J Infect Dis 191: 1808–16
Ho GYF, Bierman R, Beardsley L et al. (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–8
Woodman CBJ, Collins S, Winter H et al. (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831–6
Winer RL, Lee SK, Hughes JP et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218–26
Winer RL, Kiviat NB, Hughes JP et al. (2005) Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191: 731–8
Moscicki AB, Hills N, Shiboski S et al. (2001) Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285: 2995–3002
Schlecht NF, Kulaga S, Robitaille J et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286: 3106–14
Moscicki AB, Shiboski S, Hills NK et al. (2004) Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364: 1678–83
Schlecht NF, Platt RW, Duarte-Franco E et al. (2003) Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 95: 1336–43
Rozendaal L, Walboomers JMM, van der Linden JC et al. (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68: 766–9
Nobbenhuis MAE, Walboomers JMM, Helmerhorst TJM et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20–5
Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12: 186–92
Melnikow J, Nuovo J, Willan AR et al. (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92: 727–35
Ho GYF, Studentsov YY, Bierman R et al. (2004) Natural history of human papillomavirus type16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 13: 110–6
Hildesheim A, Wang SS. (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89: 229–40
Heard I, Tassie JM, Schmitz V et al. (2000) Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 96: 403–9
Sastre-Garau X, Cartier I, Jourdan-Da Silva N et al. (2004) Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1⋆13 genotype. Obstet Gynecol 104: 751–5
Frazer IH (2004) Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4: 46–54
Hernandez PA, Gorlin RJ, Lukens JN et al. (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34: 70–4
Bosch FX, Lorincz A, Meijer CJLM et al. (2005) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 22: 244–65
Munoz N, Bosch FX, Castellsagué X et al. (2002) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111: 278–85
Clifford GM, Smith JS, Plummer M et al. (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63–73
Clifford GM, Smith JS, Aguado T et al. (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis Br J Cancer 89: 101–5
Schneider-Maunoury S, Croissant O, Orth G (1987) Integration of human papillomavirus type 16 DNA sequences. A possible early event in the progression of genital tumors. J Virol 61: 3295–8
Santin AD, Zhan F, Bignotti E et al. (2005) Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331: 269–91
ASCUS-LSIL Triage Study (ALTS) Group (2003) Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188: 1383–92
Arbyn M, Buntix F, Van Ranst M et al. (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Institute 96: 280–93
Herrero R, Hildesheim A, Bratti C et al. (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464–74
Sherman ME, Schiffman M, Cox JT (2002) Effects of age and human papilloma viral load on colposcopy triage; data from the randomized atypical squamous cells of undermined significance / low-grade squamous intraepithelial lesions triage study (ALTS). J Natl Cancer Inst 94: 102–7
Cuzick J, Szarewski A, Cubie H et al. (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871–6
Agence nationale d’accréditation et d’évaluation en santé (2004) Évaluation de l’intérêt de la recherche des papillomavirus (PVH) dans le dépistage des lésions précancéreuses et cancéreuses du col de l’utérus. (site: www.anaes.fr)
Klaes R, Benner A, Friedrich T et al. (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26: 1389–99
Koutsky LA, Ault KA, Wheeler CM et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–51
Harper DM, Franco EL, Wheeler C et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 364: 1757–65
Villa LL, Costa RLR, Petta CA et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet 6: 271–8
Cohen J (2005) High hopes and dilemmas for a cervical cancer vaccine. Science 308: 618–21
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag France
About this chapter
Cite this chapter
Orth, G. (2005). Les papillomavirus humains et leur rôle dans l’histoire naturelle du cancer du col de l’utérus. Perspectives dans le domaine de la prévention de ce cancer. In: Le dépistage du cancer du col de l’utérus. Dépistage et cancer. Springer, Paris. https://doi.org/10.1007/2-287-28699-3_1
Download citation
DOI: https://doi.org/10.1007/2-287-28699-3_1
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-22083-8
Online ISBN: 978-2-287-28699-5